Metabolomics Market (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Worth $1.5 Billion by 2017 - Report by MarketsandMarkets

• 

MarketsandMarkets

Key Players - METABOLON (U.S.), METANOMICS (GERMANY), HUMAN METABOLOME TECNOLOGY (JAPAN), AGILENT (U.S), BRUKER CORPORATION (U.S.). Other players involved include Beckman Coulter (U.S.), Waters Corporation (U.S.), Biocrates Lifesciences (Austria)

(PRWEB) April 13, 2014

The report "Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017" analyses the global metabolomics market by region, applications and indications with five year revenue forecasts. It also identifies the factors driving and restraining the global metabolomics market with analysis of trends, opportunities and challenges.

The market is segmented and the revenue is forecasted on the basis of major regions such as America, Europe, Asia and Rest of the World (ROW) covering the key countries for each region. Further, the market is also segmented and revenues are forecasted on the basis of applications and disease indications.

Ask for Free PDf Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=900

Browse 17 market data tables and 36 figures spread through 136 slides and in-depth TOC on "Metabolomics Market"
http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html

Early buyers will receive 10% customization on this report.

The global market for metabolomics in terms of revenue is estimated to be worth $343 million in 2012 and is expected to reach $1.5 billion by 2017, growing at a CAGR of 35% from 2012 to 2017.

Inquire Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=900

In the post genomic era, metabolomics is gaining importance as another promising “omic” technology for understanding the biology of various diseases. Rapid advancement has been occurring in prediction, detection, monitoring and understanding of various diseases using metabolomic technologies.

The market for metabolomic data analysis tools and software is increasing at a higher rate. Metabolomics allows pharma companies to stretch their R&D efforts by improving efficiency in target discovery and validation, mode-of-action, and toxicology studies. There has been a significant global growth in biotechnology and pharmaceutical industries in the last decade and the market is expected to have a double-digit growth rate in the coming years.

Biomarker discovery services and increased need for toxicity testing are driving the metabolomics market. Nutraceuticals, plant genomics, nutri-genomics, systems biology are some high growth and emerging application areas that are expected to drive the global market of metabolomics in coming years.

Market is witnessing the increased willingness of biotechnology and pharma companies to adopt metabolomics concept which is likely to drive the research and development (R&D) activity within the industry.

Metabolomic research is already equipped with sophisticated tools and growth in the segment will be driven by additional improvements to the existing technologies. A large number of R&D projects are focused on use of metabolite profiles as crucial tools in drug discovery. The research extends potential cost-saving benefits, especially in toxicology studies that involve metabolic profiling of samples exposed to investigational drugs.

Bioinformatics tools greatly aid the growth of the metabolomics market with advancements in product offerings and growth in the number of market participants. Nuclear magnetic resonance and mass spectrometry represent two traditional, key platforms used for metabolomics study.

The key players in the metabolomics market were identified through secondary research and their revenue is determined through primary and secondary research. This also includes study of the annual reports of top market participants.

Browse Related Reports:
Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/aptamers-technology-market-1167.html

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 2018)
http://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market-43.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

PDF Print